WIDDER; Kenneth J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for WIDDER; Kenneth J..The latest application filed is for "ophthalmic composition".
Company Profile
19.29.29
- WIDDER; Kenneth J. - Rancho Santa Fe CA
- Widder; Kenneth J. - Rancho Sante Fe CA
- Widder; Kenneth J. - Del Mar CA
- Widder; Kenneth J. - Chicago IL
- Widder; Kenneth J. - Carboro NC
Patent Activity
| Patent | Date |
|---|---|
| Ophthalmic Composition App 20220265632 - OSTROW; Gregory I. ; et al. | 2022-08-25 |
| Ophthalmic Composition App 20220265631 - OSTROW; Gregory I. ; et al. | 2022-08-25 |
| Ophthalmic composition Grant 11,382,909 - Ostrow , et al. July 12, 2 | 2022-07-12 |
| D2o Stabilized Pharmaceutical Formulations App 20210393649 - OSTROW; Gregory I. ; et al. | 2021-12-23 |
| D2o Stabilized Pharmaceutical Formulations App 20210283142 - OSTROW; Gregory I. ; et al. | 2021-09-16 |
| Ophthalmic Composition App 20210213008 - OSTROW; Gregory I. ; et al. | 2021-07-15 |
| D2O stabilized pharmaceutical formulations Grant 11,052,095 - Ostrow , et al. July 6, 2 | 2021-07-06 |
| D.sub.2O stabilized pharmaceutical formulations Grant 11,052,094 - Ostrow , et al. July 6, 2 | 2021-07-06 |
| Ophthalmic composition Grant 10,953,002 - Ostrow , et al. March 23, 2 | 2021-03-23 |
| Ophthalmic composition Grant 10,940,145 - Ostrow , et al. March 9, 2 | 2021-03-09 |
| Ophthalmic Composition App 20210059998 - OSTROW; Gregory I. ; et al. | 2021-03-04 |
| Ophthalmic composition Grant 10,888,557 - Ostrow , et al. January 12, 2 | 2021-01-12 |
| Ophthalmic composition Grant 10,864,208 - Ostrow , et al. December 15, 2 | 2020-12-15 |
| Ophthalmic composition Grant 10,842,787 - Ostrow , et al. November 24, 2 | 2020-11-24 |
| Ophthalmic Composition And Delivery Device Thereof App 20200345542 - OSTROW; Gregory I. ; et al. | 2020-11-05 |
| Ophthalmic Composition App 20200338060 - OSTROW; Gregory I. ; et al. | 2020-10-29 |
| Ophthalmic composition Grant 10,813,923 - Ostrow , et al. October 27, 2 | 2020-10-27 |
| Ophthalmic Composition App 20200316052 - OSTROW; Gregory I. ; et al. | 2020-10-08 |
| Ophthalmic Composition App 20200306239 - OSTROW; Gregory I. ; et al. | 2020-10-01 |
| Ophthalmic Composition App 20200297712 - OSTROW; Gregory I. ; et al. | 2020-09-24 |
| Ophthalmic Composition App 20200297713 - OSTROW; Gregory I. ; et al. | 2020-09-24 |
| Ophthalmic Composition App 20200297714 - OSTROW; Gregory I. ; et al. | 2020-09-24 |
| D2o Stabilized Pharmaceutical Formulations App 20200197410 - OSTROW; Gregory I. ; et al. | 2020-06-25 |
| Ophthalmic Composition App 20200085813 - OSTROW; Gregory I. ; et al. | 2020-03-19 |
| Ophthalmic Composition App 20190298707 - OSTROW; Gregory I. ; et al. | 2019-10-03 |
| Ophthalmic Composition App 20190091213 - OSTROW; Gregory I. ; et al. | 2019-03-28 |
| Ophthalmic composition Grant 10,201,534 - Ostrow , et al. Feb | 2019-02-12 |
| Ophthalmic Composition Grant 10,076,515 - Ostrow , et al. September 18, 2 | 2018-09-18 |
| Ophthalmic Composition App 20180193326 - OSTROW; Gregory I. ; et al. | 2018-07-12 |
| D20 Stabilized Pharmaceutical Formulations App 20180147214 - OSTROW; Gregory I. ; et al. | 2018-05-31 |
| Ophthalmic Composition App 20180042911 - OSTROW; Gregory I. ; et al. | 2018-02-15 |
| Ophthalmic composition Grant 9,770,447 - Ostrow , et al. September 26, 2 | 2017-09-26 |
| Ophthalmic Composition App 20160339007 - OSTROW; Gregory I. ; et al. | 2016-11-24 |
| Ophthalmic composition Grant 9,421,199 - Ostrow , et al. August 23, 2 | 2016-08-23 |
| Ophthalmic Composition App 20160009705 - Ostrow; Gregory I. ; et al. | 2016-01-14 |
| Ophthalmic Composition App 20150366854 - Ostrow; Gregory I. ; et al. | 2015-12-24 |
| Method of improved diuresis in individuals with impaired renal function Grant 7,579,331 - Widder , et al. August 25, 2 | 2009-08-25 |
| Method Of Treatment Of Cardiac And/or Renal Failure Using A Calcium Channel Blocker And An Angiotensin Converting Enzyme Inhibitor Or An Angiotensin Ii Receptor Blocker App 20090118334 - Dittrich; Howard C. ; et al. | 2009-05-07 |
| Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin II receptor blocker App 20060058355 - Dittrich; Howard C. ; et al. | 2006-03-16 |
| Method of improved diuresis in individuals with impaired renal function App 20060035911 - Widder; Kenneth J. ; et al. | 2006-02-16 |
| Method of improved diuresis in individuals with impaired renal function App 20060030572 - Widder; Kenneth J. ; et al. | 2006-02-09 |
| Method of improved diuresis in individuals with impaired renal function App 20050004145 - Widder, Kenneth J. ; et al. | 2005-01-06 |
| Method of treatment of disease using an adenosine A1 receptor antagonist App 20040229901 - Otsuki, Lauren ; et al. | 2004-11-18 |
| Method of ultrasonically quantitating myocardial perfusion using as intravenously injected tracer Grant 5,732,707 - Widder , et al. March 31, 1 | 1998-03-31 |
| Emulsions as contrast agents and method of use Grant 5,716,597 - Lohrmann , et al. February 10, 1 | 1998-02-10 |
| Emulsions as contrast agents and method of use Grant 5,536,489 - Lohrmann , et al. July 16, 1 | 1996-07-16 |
| Method of ultrasonic imaging of the gastrointestinal tract and upper abdominal organs using an orally administered negative contrast medium Grant 5,385,147 - Anderson , et al. January 31, 1 | 1995-01-31 |
| Method of ultrasonic imaging of body cavities Grant 5,373,846 - Widder December 20, 1 | 1994-12-20 |
| Method of magnetic resonance imaging using diamagnetic contrast Grant 5,315,997 - Widder , et al. May 31, 1 | 1994-05-31 |
| Method of abdominal ultrasound imaging Grant 5,179,955 - Levene , et al. * January 19, 1 | 1993-01-19 |
| Method of ultrasound imaging of the gastrointestinal tract Grant 5,107,842 - Levene , et al. April 28, 1 | 1992-04-28 |
| Magnetic resonance imaging of liver and spleen with superparamagnetic contrast agents Grant 4,849,210 - Widder * July 18, 1 | 1989-07-18 |
| Concentrated stabilized microbubble-type ultrasonic imaging agent Grant 4,844,882 - Widder , et al. July 4, 1 | 1989-07-04 |
| Method of magnetic resonance imaging of the liver and spleen Grant 4,675,173 - Widder June 23, 1 | 1987-06-23 |
| Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres Grant 4,357,259 - Senyei , et al. November 2, 1 | 1982-11-02 |
| Method of delivering a therapeutic agent to a target capillary bed Grant 4,345,588 - Widder , et al. August 24, 1 | 1982-08-24 |
| Intravascularly-administrable, magnetically-localizable biodegradable carrier Grant 4,247,406 - Widder , et al. January 27, 1 | 1981-01-27 |
| Method of magnetic separation of cells and the like, and microspheres for use therein Grant 4,230,685 - Senyei , et al. October 28, 1 | 1980-10-28 |
Company Registrations
| SEC | 0001065168 | WIDDER KENNETH J |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 